Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Women in Cannabis Study (WICS) is a research and data analytics company focused on documenting and analyzing the experiences of women and non-binary individuals within the global cannabis, hemp, and CBD industries. Founded by Jennifer Whetzel of Ladyjane Branding, the company conducts large-scale longitudinal studies to provide quantitative and qualitative insights into professional trajectories, health outcomes, and industry barriers. WICS produces comprehensive reports that serve as a baseline for industry inclusivity and consumer behavior, particularly regarding therapeutic cannabis use for women's health. The company's work is utilized by businesses, policy advocates, and healthcare professionals to better understand the female demographic in the evolving legal landscape. By leveraging data storytelling, WICS aims to drive systemic change and foster a more equitable and wellness-focused cannabis ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Women in Cannabis.